Skip to main content
ConductScienceScienceDex

Nicholas H. Oberlies

NIH Rank #7690
Unclaimed recordClaim profile
  • Program Leader
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6201729Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2024

Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#7,690
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Nicholas H. Oberlies. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Nicholas H. Oberlies as a PI. Multi-PI records show the full award amount for context.

  • 5R44CA285062-02R44
    Assigning mode of action to phenotypically discovered anticancer leads.
    Attagene, Inc.
    $1M
    award amount
  • 5U54AT008909-10U54
    Natural Product-Drug Interaction Research: The Roadmap to Best Practices
    Washington State University
    $470.7K
    award amount
  • 5P01CA125066-15P01
    Discovery of Anticancer Agents of Diverse Natural Origin
    Ohio State University
    $143.3K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Nicholas H. Oberlies as a PI.

Attagene, Inc.
NC
$1M
1 grant
Washington State University
WA
$470.7K
1 grant
Ohio State University
OH
$143.3K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Attagene, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7690
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 3 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Nicholas H. Oberlies.

Alan Douglas Kinghorn
Ohio State University
2
shared awards
James R Fuchs
Ohio State University
2
shared awards
Jimmy Orjala
Ohio State University
2
shared awards
Joanna E Burdette
Ohio State University
2
shared awards
Mary Frances Paine
Washington State University
1
shared award
Richard David Boyce
Washington State University
1
shared award
Sergei S Makarov
Attagene, Inc.
1
shared award
Sergei S Makarov
Attagene, Inc.
1
shared award

Explore further

Find collaborators for Nicholas H. Oberlies

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →